Crossmark

Representation of people with comorbidity and multimorbidity in clinical trials of novel drug therapies: an individual-level participant data analysis

Crossref DOI link: https://doi.org/10.1186/s12916-019-1427-1

Published Online: 2019-11-12

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hanlon, Peter http://orcid.org/0000-0002-5828-3934
Hannigan, Laurie

Rodriguez-Perez, Jesus

Fischbacher, Colin

Welton, Nicky J.

Dias, Sofia

Mair, Frances S.

Guthrie, Bruce

Wild, Sarah

McAllister, David A.
Funding

Funding for this research was provided by:

Wellcome Trust (201492-Z-16-Z)

Medical Research Council (MR/S021949/1)
License Information

Text and Data Mining valid from 2019-11-12

Version of Record valid from 2019-11-12
More Information

Article History

Received: 6 May 2019

Accepted: 17 September 2019

First Online: 12 November 2019

Ethics approval and consent to participate

: This project had approval from the University of Glasgow, College of Medicine, Veterinary and Life Sciences ethics committee (200160070). SAIL analyses were approved by SAIL Information Governance Review Panel (Project 0830).

: Not applicable

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below